-
1
-
-
1642428961
-
-
6th ed. American Joint Committee on Cancer. New York: Springer
-
Cancer Staging Handbook, 6th ed. American Joint Committee on Cancer. New York: Springer, 2002.
-
(2002)
Cancer Staging Handbook
-
-
-
2
-
-
0037093947
-
Annual Report to the nation of the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden
-
Edwards, et al. Annual Report to the nation of the status of cancer, 1973-1999, featuring implications of age and aging on US cancer burden. Cancer 2002;94:2766-2792.
-
(2002)
Cancer
, vol.94
, pp. 2766-2792
-
-
Edwards, A.1
-
3
-
-
0035846320
-
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients
-
Sargent, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001;345:1091-1097.
-
(2001)
N. Engl. J. Med.
, vol.345
, pp. 1091-1097
-
-
Sargent, A.1
-
4
-
-
0036789418
-
Effectiveness of adjuvant fluorouracil in clinical practice: A population-based cohort study of elderly patients with stage iii colon cancer
-
Iwashyna, et al. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage iii colon cancer. J Clin Oncol 20:3992-3998.
-
J. Clin. Oncol.
, vol.20
, pp. 3992-3998
-
-
Iwashyna, A.1
-
5
-
-
0031431422
-
Psychological reactions in newly diagnosed GI cancer patients
-
Nordin, et al. Psychological reactions in newly diagnosed GI cancer patients. Acta Oncol 36:803-810.
-
Acta Oncol.
, vol.36
, pp. 803-810
-
-
Nordin, A.1
-
6
-
-
0036787781
-
Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer
-
Schrag, et al. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol 20:3999-4005.
-
J. Clin. Oncol.
, vol.20
, pp. 3999-4005
-
-
Schrag, A.1
-
7
-
-
0035883421
-
High-risk groups of patients with stage II colon carcinoma
-
Merkel, et al. High-risk groups of patients with stage II colon carcinoma. Cancer 2001;92:1435-1443.
-
(2001)
Cancer
, vol.92
, pp. 1435-1443
-
-
Merkel, A.1
-
8
-
-
85030911060
-
-
Guidelines available online at: www.nccn.org/physicians/fidelines.html
-
Guidelines available online at: www.nccn.org/physicians/fidelines.html.
-
-
-
-
10
-
-
0027514914
-
Psycho-oncology: Psychological well-being as one component of quality of life
-
Tope, et al. Psycho-oncology: Psychological well-being as one component of quality of life. Psychother Psychosom 1993;60:129-147.
-
(1993)
Psychother Psychosom
, vol.60
, pp. 129-147
-
-
Tope, A.1
-
11
-
-
85030898546
-
Organic mental changes with fluorouracil therapy
-
[Letter]
-
Greenwald E. Organic mental changes with fluorouracil therapy [Letter]. JAMA 235.
-
JAMA
, pp. 235
-
-
Greenwald, E.1
-
12
-
-
0020686106
-
Chemotherapy and cognitive defects in cancer patients
-
Silberfarb, et al. Chemotherapy and cognitive defects in cancer patients. Annu Rev Med 1983;34:35-46.
-
(1983)
Annu. Rev. Med.
, vol.34
, pp. 35-46
-
-
Silberfarb, A.1
-
13
-
-
0028827867
-
Disabling encephalopathy during 5-fluorouracil and levamisole adjuvant chemotherapy for resected colorectal cancer
-
Figueredo, et al. Disabling encephalopathy during 5-fluorouracil and levamisole adjuvant chemotherapy for resected colorectal cancer. Cancer Invest 13:608-611.
-
Cancer Invest.
, vol.13
, pp. 608-611
-
-
Figueredo, A.1
-
14
-
-
0032481412
-
Impairment of cognitive function in women receiving adjuvant treatment for high risk breast cancer: High dose vs. standard dose chemotherapy
-
van Dam, et al. Impairment of cognitive function in women receiving adjuvant treatment for high risk breast cancer: High dose vs. standard dose chemotherapy. J Natl Cancer Inst 90:210-218.
-
J. Natl. Cancer Inst.
, vol.90
, pp. 210-218
-
-
van Dam, A.1
-
15
-
-
0033082318
-
Cognitive deficits after postoperative adjuvant chemotherapy for breast cancer
-
Shagen, et al. Cognitive deficits after postoperative adjuvant chemotherapy for breast cancer. Cancer 85:640-650.
-
Cancer
, vol.85
, pp. 640-650
-
-
Shagen, A.1
-
16
-
-
0037080459
-
Neuropsychological impact of standard dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma
-
Ahles, et al. Neuropsychological impact of standard dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485-493.
-
J. Clin. Oncol.
, vol.20
, pp. 485-493
-
-
Ahles, A.1
|